Table of Contents

June 2006, Volume 13, Number 2

Commentary

Reviews

    • A M Lorincz and
    • S Sukumar

    Molecular links between obesity and breast cancer

    Endocr Relat Cancer 13 (2) 279-292, doi:10.1677/erc.1.00729
    • Marc Lacroix,
    • Robert-Alain Toillon,
    • and Guy Leclercq

    p53 and breast cancer, an update

    Endocr Relat Cancer 13 (2) 293-325, doi:10.1677/erc.1.01172
    • Leigh C Murphy and
    • Peter H Watson

    Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

    Endocr Relat Cancer 13 (2) 327-334, doi:10.1677/erc.1.01141
    • F Labrie

    Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA

    Endocr Relat Cancer 13 (2) 335-355, doi:10.1677/erc.1.00883
    • Antoinette S Perry,
    • Ruth Foley,
    • Karen Woodson,
    • and Mark Lawler

    The emerging roles of DNA methylation in the clinical management of prostate cancer

    Endocr Relat Cancer 13 (2) 357-377, doi:10.1677/erc.1.01184
    • Markus C Fleisch,
    • Christopher A Maxwell,
    • and Mary-Helen Barcellos-Hoff

    The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs

    Endocr Relat Cancer 13 (2) 379-400, doi:10.1677/erc.1.01112
    • J-R Weng,
    • C-Y Chen,
    • J J Pinzone,
    • M D Ringel,
    • and C-S Chen

    Beyond peroxisome proliferator-activated receptor γ signaling: the multi-facets of the antitumor effect of thiazolidinediones

    Endocr Relat Cancer 13 (2) 401-413, doi:10.1677/erc.1.01182
    • Emma R Woodward and
    • Eamonn R Maher

    Von Hippel-Lindau disease and endocrine tumour susceptibility

    Endocr Relat Cancer 13 (2) 415-425, doi:10.1677/erc.1.00683
    • M Niedziela

    Pathogenesis, diagnosis and management of thyroid nodules in children

    Endocr Relat Cancer 13 (2) 427-453, doi:10.1677/erc.1.00882

Research

    • L Fugazzola,
    • E Puxeddu,
    • N Avenia,
    • C Romei,
    • V Cirello,
    • A Cavaliere,
    • P Faviana,
    • D Mannavola,
    • S Moretti,
    • S Rossi,
    • M Sculli,
    • V Bottici,
    • P Beck-Peccoz,
    • F Pacini,
    • A Pinchera,
    • F Santeusanio,
    • and R Elisei

    Correlation between B-RAFV600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature

    Endocr Relat Cancer 13 (2) 455-464, doi:10.1677/erc.1.01086
    • Päivi Siironen,
    • Ari Ristimäki,
    • Kirsi Narko,
    • Stig Nordling,
    • Johanna Louhimo,
    • Sture Andersson,
    • Reijo Haapiainen,
    • and Caj Haglund

    VEGF-C and COX-2 expression in papillary thyroid cancer

    Endocr Relat Cancer 13 (2) 465-473, doi:10.1677/erc.1.01114
    • A Bakhsh,
    • G Kirov,
    • J W Gregory,
    • E D Williams,
    • and M Ludgate

    A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer

    Endocr Relat Cancer 13 (2) 475-483, doi:10.1677/erc.1.01138
    • J Di Cristofaro,
    • M Silvy,
    • A Lanteaume,
    • M Marcy,
    • P Carayon,
    • and C De Micco

    Expression of tpo mRNA in thyroid tumors: quantitiative PCR analysis and correlation with alterations of ret, Braf , ras and pax8 genes

    Endocr Relat Cancer 13 (2) 485-495, doi:10.1677/erc.1.01164
    • P Pallante,
    • R Visone,
    • M Ferracin,
    • A Ferraro,
    • M T Berlingieri,
    • G Troncone,
    • G Chiappetta,
    • C G Liu,
    • M Santoro,
    • M Negrini,
    • C M Croce,
    • and A Fusco

    MicroRNA deregulation in human thyroid papillary carcinomas

    Endocr Relat Cancer 13 (2) 497-508, doi:10.1677/erc.1.01209
    • C Juhlin,
    • C Larsson,
    • T Yakoleva,
    • I Leibiger,
    • B Leibiger,
    • A Alimov,
    • G Weber,
    • A Höög,
    • and A Villablanca

    Loss of parafibromin expression in a subset of parathyroid adenomas

    Endocr Relat Cancer 13 (2) 509-523, doi:10.1677/erc.1.01058
    • D Cecchin,
    • F Lumachi,
    • M C Marzola,
    • G Opocher,
    • C Scaroni,
    • P Zucchetta,
    • F Mantero,
    • and F Bui

    A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma

    Endocr Relat Cancer 13 (2) 525-533, doi:10.1677/erc.1.01066
    • David J Gross,
    • Gabriel Munter,
    • Menachem Bitan,
    • Tali Siegal,
    • Alberto Gabizon,
    • Ronny Weitzen,
    • Ofer Merimsky,
    • Aliza Ackerstein,
    • Asher Salmon,
    • Avishai Sella,
    • Shimon Slavin,
    • and The Israel Glivec in Solid Tumors Study Group
    • , The Israel Glivec in Solid Tumors Study Group

    The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

    Endocr Relat Cancer 13 (2) 535-540, doi:10.1677/erc.1.01124
    • G Capurso,
    • S Lattimore,
    • T Crnogorac-Jurcevic,
    • F Panzuto,
    • M Milione,
    • V Bhakta,
    • N Campanini,
    • S M Swift,
    • C Bordi,
    • G Delle Fave,
    • and N R Lemoine

    Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

    Endocr Relat Cancer 13 (2) 541-558, doi:10.1677/erc.1.01153
    • M Marino,
    • P Galluzzo,
    • S Leone,
    • F Acconcia,
    • and P Ascenzi

    Nitric oxide impairs the 17β-estradiol-induced apoptosis in human colon adenocarcinoma cells

    Endocr Relat Cancer 13 (2) 559-569, doi:10.1677/erc.1.01106
    • Z Attias,
    • H Werner,
    • and N Vaisman

    Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner

    Endocr Relat Cancer 13 (2) 571-581, doi:10.1677/erc.1.01156
    • Eva S Schernhammer,
    • Jeff M Holly,
    • David J Hunter,
    • Michael N Pollak,
    • and Susan E Hankinson

    Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II

    Endocr Relat Cancer 13 (2) 583-592, doi:10.1677/erc.1.01149
    • S Rinaldi,
    • P H M Peeters,
    • F Berrino,
    • L Dossus,
    • C Biessy,
    • A Olsen,
    • A Tjonneland,
    • K Overvad,
    • F Clavel-Chapelon,
    • M C Boutron-Ruault,
    • B Téhard,
    • G Nagel,
    • J Linseisen,
    • H Boeing,
    • P H Lahmann,
    • A Trichopoulou,
    • D Trichopoulos,
    • M Koliva,
    • D Palli,
    • S Panico,
    • R Tumino,
    • C Sacerdote,
    • C H van Gils,
    • P van Noord,
    • D E Grobbee,
    • H B Bueno-de-Mesquita,
    • C A Gonzalez,
    • A Agudo,
    • M D Chirlaque,
    • A Barricarte,
    • N Larrañaga,
    • J R Quiros,
    • S Bingham,
    • K T Khaw,
    • T Key,
    • N E Allen,
    • A Lukanova,
    • N Slimani,
    • R Saracci,
    • E Riboli,
    • and R Kaaks

    IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC)

    Endocr Relat Cancer 13 (2) 593-605, doi:10.1677/erc.1.01150
    • C Montagut,
    • I Tusquets,
    • B Ferrer,
    • J M Corominas,
    • B Bellosillo,
    • C Campas,
    • M Suarez,
    • X Fabregat,
    • E Campo,
    • P Gascon,
    • S Serrano,
    • P L Fernandez,
    • A Rovira,
    • and J Albanell

    Activation of nuclear factor-κ B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients

    Endocr Relat Cancer 13 (2) 607-616, doi:10.1677/erc.1.01171
    • C L Wilson,
    • A H Sims,
    • A Howell,
    • C J Miller,
    • and R B Clarke

    Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue

    Endocr Relat Cancer 13 (2) 617-628, doi:10.1677/erc.1.01165
    • D Sharma,
    • N K Saxena,
    • P M Vertino,
    • and F A Anania

    Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways

    Endocr Relat Cancer 13 (2) 629-640, doi:10.1677/erc.1.01169
    • Jung-Hye Choi,
    • Kyung-Chul Choi,
    • Nelly Auersperg,
    • and Peter C K Leung

    Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells

    Endocr Relat Cancer 13 (2) 641-651, doi:10.1677/erc.1.01057
|

This Issue

June 2006; 13 (2)
Cover
  1. Commentary
  2. Reviews
  3. Research

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most